Signal or noise? > FDA Acceptance Of Rocket Pharmaceuticals' Lead Gene Therapy
Application Reestablishes Momentum For Stock - Benzinga >> Comment below! #strategy #competitiveintelligence #marketing #competitivemarketing #biotech #pharmaceutical #healthcare #pharma
Application Reestablishes Momentum For Stock - Benzinga >> Comment below! #strategy #competitiveintelligence #marketing #competitivemarketing #biotech #pharmaceutical #healthcare #pharma
FDA Acceptance Of Rocket Pharmaceuticals' Lead Gene Therapy
Application Reestablishes Momentum For Stock - Benzinga
FDA Acceptance Of Rocket Pharmaceuticals' Lead Gene Therapy Application Reestablishes Momentum For Stock Benzinga
dlvr.it
October 14, 2025 at 8:59 PM
Everybody can reply
1 likes
Signal or noise? > Q&A: Scientists behind Baby KJ’s custom CRISPR drug
are planning to help more children >> Comment below! #strategy #competitiveintelligence #marketing #biotech #healthcare #pharmaceutical #pharma #productmarketing
are planning to help more children >> Comment below! #strategy #competitiveintelligence #marketing #biotech #healthcare #pharmaceutical #pharma #productmarketing
Q&A: Scientists behind Baby KJ’s custom CRISPR drug
are planning to help more children
SEVILLE, SPAIN — Earlier this year, the long-held dream of personalized gene editing was made real with the creation of a base editing therapy to correct the unique mutation that caused “Baby KJ’s” rare and otherwise ...
dlvr.it
October 9, 2025 at 2:37 AM
Everybody can reply
2 likes
Signal or noise? > JCR Pharmaceuticals Enhances Delivery of AAV Gene Therapy to
Central Nervous System and Muscle with Novel Capsid Engineering
Platform Technology -… >> Comment below! #strategy #competitiveintelligence #marketing #healthcare #pharmaceutical #pharma #competitivemarketing #biotech
Central Nervous System and Muscle with Novel Capsid Engineering
Platform Technology -… >> Comment below! #strategy #competitiveintelligence #marketing #healthcare #pharmaceutical #pharma #competitivemarketing #biotech
JCR Pharmaceuticals Enhances Delivery of AAV Gene Therapy to
Central Nervous System and Muscle with Novel Capsid Engineering
Platform Technology - Yahoo
JCR Pharmaceuticals Enhances Delivery of AAV Gene Therapy to Central Nervous System and Muscle with Novel Capsid Engineering Platform Technology Yahoo
dlvr.it
October 7, 2025 at 5:31 PM
Everybody can reply
1 likes
Thoughts on this? >> 5 FDA Decisions to Watch in Q1 - BioSpace: 5 FDA Decisions to Watch in Q1 BioSpace >> Comment below! #strategy #competitiveintelligence #marketing #pharma #pharmaceutical #competitivemarketing #biotech #healthcare
5 FDA Decisions to Watch in Q1 - BioSpace
5 FDA Decisions to Watch in Q1 BioSpace
dlvr.it
January 6, 2025 at 6:30 AM
Everybody can reply
Thoughts on this? >> Biopharma to raise more than 1,000 drug prices in 2025,
advisory firm predicts: Drugmakers are expected to increase list prices on more than 1,000… >> Comment below! #strategy #competitiveintelligence #marketing #productmarketing #biotech #healthcare #pharma #pharmaceutical
advisory firm predicts: Drugmakers are expected to increase list prices on more than 1,000… >> Comment below! #strategy #competitiveintelligence #marketing #productmarketing #biotech #healthcare #pharma #pharmaceutical
Biopharma to raise more than 1,000 drug prices in 2025,
advisory firm predicts
Drugmakers are expected to increase list prices on more than 1,000 medicines this year, and already raised the prices on about 250 drugs on Jan. 1, according to an analysis by the consultancy firm 3 ...
dlvr.it
January 3, 2025 at 12:57 AM
Everybody can reply
Thoughts on this? >> European Medicines Agency recommends ‘landmark’ gene therapy
for epidermolysis bullosa - Healio: European Medicines Agency recommends ‘landmark’… >> Comment below! #strategy #competitiveintelligence #marketing #pharmaceutical #healthcare #competitivemarketing #biotech #pharma
for epidermolysis bullosa - Healio: European Medicines Agency recommends ‘landmark’… >> Comment below! #strategy #competitiveintelligence #marketing #pharmaceutical #healthcare #competitivemarketing #biotech #pharma
European Medicines Agency recommends ‘landmark’ gene therapy
for epidermolysis bullosa - Healio
European Medicines Agency recommends ‘landmark’ gene therapy for epidermolysis bullosa Healio
dlvr.it
February 28, 2025 at 7:31 PM
Everybody can reply
Thoughts on this? >> Avirmax Biopharma Initiates IND-enabling Studies of ABI-201;
a Breakthrough Gene Therapy for Dry Age-related Macular
Degeneration - PR Newswire:… >> Comment below! #strategy #competitiveintelligence #marketing #healthcare #pharma #pharmaceutical #biotech #competitivemarketing
a Breakthrough Gene Therapy for Dry Age-related Macular
Degeneration - PR Newswire:… >> Comment below! #strategy #competitiveintelligence #marketing #healthcare #pharma #pharmaceutical #biotech #competitivemarketing
Avirmax Biopharma Initiates IND-enabling Studies of ABI-201;
a Breakthrough Gene Therapy for Dry Age-related Macular
Degeneration - PR Newswire
Avirmax Biopharma Initiates IND-enabling Studies of ABI-201; a Breakthrough Gene Therapy for Dry Age-related Macular Degeneration PR Newswire
dlvr.it
February 28, 2025 at 7:31 PM
Everybody can reply
Thoughts on this? >> Sarepta Q4 Earnings Lag Estimates, Revenues Gain on Gene
Therapy Sales - Zacks Investment Research: Sarepta Q4 Earnings Lag Estimates, Revenues… >> Comment below! #strategy #competitiveintelligence #marketing #pharma #pharmaceutical #competitivemarketing #biotech #healthcare
Therapy Sales - Zacks Investment Research: Sarepta Q4 Earnings Lag Estimates, Revenues… >> Comment below! #strategy #competitiveintelligence #marketing #pharma #pharmaceutical #competitivemarketing #biotech #healthcare
Sarepta Q4 Earnings Lag Estimates, Revenues Gain on Gene
Therapy Sales - Zacks Investment Research
Sarepta Q4 Earnings Lag Estimates, Revenues Gain on Gene Therapy Sales Zacks Investment Research
dlvr.it
February 27, 2025 at 2:01 PM
Everybody can reply
Thoughts on this? >> Gene Doping in Horse Sport: Concerns and Perspectives - Equi
Management: Gene Doping in Horse Sport: Concerns and Perspectives Equi Management >> Comment below! #strategy #competitiveintelligence #marketing #pharmaceutical #biotech #pharma #competitivemarketing #healthcare
Management: Gene Doping in Horse Sport: Concerns and Perspectives Equi Management >> Comment below! #strategy #competitiveintelligence #marketing #pharmaceutical #biotech #pharma #competitivemarketing #healthcare
Gene Doping in Horse Sport: Concerns and Perspectives - Equi
Management
Gene Doping in Horse Sport: Concerns and Perspectives Equi Management
dlvr.it
March 8, 2025 at 8:00 PM
Everybody can reply
Thoughts on this? >> Acute liver failure death casts pall on Elevidys commercial
trajectory - FirstWord Pharma: Acute liver failure death casts pall on Elevidys… >> Comment below! #strategy #competitiveintelligence #marketing #pharmaceutical #biotech #competitivemarketing #pharma #healthcare
trajectory - FirstWord Pharma: Acute liver failure death casts pall on Elevidys… >> Comment below! #strategy #competitiveintelligence #marketing #pharmaceutical #biotech #competitivemarketing #pharma #healthcare
Acute liver failure death casts pall on Elevidys commercial
trajectory - FirstWord Pharma
Acute liver failure death casts pall on Elevidys commercial trajectory FirstWord Pharma
dlvr.it
March 18, 2025 at 3:01 PM
Everybody can reply
Thoughts on this? >> Paratek to acquire Optinose and its nasal spray
Xhance: Paratek Pharmaceuticals is expanding beyond antibiotics and infectious disease by paying up to… >> Comment below! #strategy #competitiveintelligence #marketing #biotech #productmarketing #healthcare #pharmaceutical #pharma
Xhance: Paratek Pharmaceuticals is expanding beyond antibiotics and infectious disease by paying up to… >> Comment below! #strategy #competitiveintelligence #marketing #biotech #productmarketing #healthcare #pharmaceutical #pharma
Paratek to acquire Optinose and its nasal spray
Xhance
Paratek Pharmaceuticals is expanding beyond antibiotics and infectious disease by paying up to $330 million to acquire Optinose and its drug-device combination for chronic rhinosinusitis (CRS). Paratek will obtain Optinose’s Xhance, which features its so…
dlvr.it
March 20, 2025 at 12:05 PM
Everybody can reply
Thoughts on this? >> Genome Editing Tools Market Set for Major Expansion as Gene
- openPR: Genome Editing Tools Market Set for Major Expansion as Gene openPR >> Comment below! #strategy #competitiveintelligence #marketing #biotech #healthcare #pharmaceutical #competitivemarketing #pharma
- openPR: Genome Editing Tools Market Set for Major Expansion as Gene openPR >> Comment below! #strategy #competitiveintelligence #marketing #biotech #healthcare #pharmaceutical #competitivemarketing #pharma
Genome Editing Tools Market Set for Major Expansion as Gene
- openPR
Genome Editing Tools Market Set for Major Expansion as Gene openPR
dlvr.it
March 20, 2025 at 10:30 AM
Everybody can reply
Thoughts on this? >> Sarepta’s Gene Therapy Under Scrutiny After Patient Death -
Therogersvillereview: Sarepta’s Gene Therapy Under Scrutiny After Patient Death… >> Comment below! #strategy #competitiveintelligence #marketing #biotech #competitivemarketing #pharma #healthcare #pharmaceutical
Therogersvillereview: Sarepta’s Gene Therapy Under Scrutiny After Patient Death… >> Comment below! #strategy #competitiveintelligence #marketing #biotech #competitivemarketing #pharma #healthcare #pharmaceutical
Sarepta’s Gene Therapy Under Scrutiny After Patient Death -
Therogersvillereview
Sarepta’s Gene Therapy Under Scrutiny After Patient Death Therogersvillereview
dlvr.it
March 19, 2025 at 10:00 PM
Everybody can reply
Thoughts on this? >> Gene therapy loses luster as investors eye quicker returns
from weight-loss drugs - TradingView: Gene therapy loses luster as investors eye quicker… >> Comment below! #strategy #competitiveintelligence #marketing #pharma #pharmaceutical #biotech #healthcare #competitivemarketing
from weight-loss drugs - TradingView: Gene therapy loses luster as investors eye quicker… >> Comment below! #strategy #competitiveintelligence #marketing #pharma #pharmaceutical #biotech #healthcare #competitivemarketing
Gene therapy loses luster as investors eye quicker returns
from weight-loss drugs - TradingView
Gene therapy loses luster as investors eye quicker returns from weight-loss drugs TradingView
dlvr.it
March 21, 2025 at 1:31 PM
Everybody can reply
Thoughts on this? >> New FDA Commissioner Marty Makary addresses staff a day
after firings >> Comment below! #strategy #competitiveintelligence #marketing #biotech #pharmaceutical #pharma #healthcare #productmarketing
after firings >> Comment below! #strategy #competitiveintelligence #marketing #biotech #pharmaceutical #pharma #healthcare #productmarketing
New FDA Commissioner Marty Makary addresses staff a day
after firings
New FDA Commissioner Marty Makary took to the stage at the regulator's Maryland headquarters on Wednesday, in his first public communication to much of the agency since Tuesday's mass firings. Acknowledging the firings, which were ...
dlvr.it
April 2, 2025 at 7:54 PM
Everybody can reply
Thoughts on this? >> Atsena secures $150m Series C funding to advance gene
therapy - World Pharmaceutical Frontiers >> Comment below! #strategy #competitiveintelligence #marketing #pharmaceutical #healthcare #biotech #pharma #competitivemarketing
therapy - World Pharmaceutical Frontiers >> Comment below! #strategy #competitiveintelligence #marketing #pharmaceutical #healthcare #biotech #pharma #competitivemarketing
Atsena secures $150m Series C funding to advance gene
therapy - World Pharmaceutical Frontiers
Atsena secures $150m Series C funding to advance gene therapy World Pharmaceutical Frontiers
dlvr.it
April 3, 2025 at 10:30 AM
Everybody can reply
Thoughts on this? >> Oncolytics Biotech® Funds Pelareorep's Ongoing Clinical
Development with a Share Purchase Agreement in Partnership with
Alumni Capital - Morningstar >> Comment below! #strategy #competitiveintelligence #marketing #pharma #competitivemarketing #biotech #healthcare #pharmaceutical
Development with a Share Purchase Agreement in Partnership with
Alumni Capital - Morningstar >> Comment below! #strategy #competitiveintelligence #marketing #pharma #competitivemarketing #biotech #healthcare #pharmaceutical
Oncolytics Biotech® Funds Pelareorep's Ongoing Clinical
Development with a Share Purchase Agreement in Partnership with
Alumni Capital - Morningstar
Oncolytics Biotech® Funds Pelareorep's Ongoing Clinical Development with a Share Purchase Agreement in Partnership with Alumni Capital Morningstar
dlvr.it
April 11, 2025 at 4:00 AM
Everybody can reply
Thoughts on this? >> CDMOs anticipate inspection bottlenecks after FDA
firings >> Comment below! #strategy #competitiveintelligence #marketing #pharmaceutical #pharma #productmarketing #biotech #healthcare
firings >> Comment below! #strategy #competitiveintelligence #marketing #pharmaceutical #pharma #productmarketing #biotech #healthcare
CDMOs anticipate inspection bottlenecks after FDA
firings
CDMOs fear that FDA site inspections might slow down due to the mass staffing cuts at the federal health agencies. While President Donald Trump's potential pharma tariffs have all drugmakers on alert ...
dlvr.it
April 11, 2025 at 2:27 PM
Everybody can reply
1 likes
Thoughts on this? >> Hemophilia Gene Therapy Market Deep Research Report with -
openPR.com >> Comment below! #strategy #competitiveintelligence #marketing #competitivemarketing #pharma #biotech #healthcare #pharmaceutical
openPR.com >> Comment below! #strategy #competitiveintelligence #marketing #competitivemarketing #pharma #biotech #healthcare #pharmaceutical
Hemophilia Gene Therapy Market Deep Research Report with -
openPR.com
Hemophilia Gene Therapy Market Deep Research Report with openPR.com
dlvr.it
April 7, 2025 at 1:00 PM
Everybody can reply
Thoughts on this? >> Behind the Headlines Episode 12–Cell and Gene Therapies, New
Genomics Tools, and Recent Partnerships - Pharmaceutical Technology
Magazine: Behind… >> Comment below! #strategy #competitiveintelligence #marketing #pharma #healthcare #pharmaceutical #biotech #competitivemarketing
Genomics Tools, and Recent Partnerships - Pharmaceutical Technology
Magazine: Behind… >> Comment below! #strategy #competitiveintelligence #marketing #pharma #healthcare #pharmaceutical #biotech #competitivemarketing
Behind the Headlines Episode 12–Cell and Gene Therapies, New
Genomics Tools, and Recent Partnerships - Pharmaceutical Technology
Magazine
Behind the Headlines Episode 12–Cell and Gene Therapies, New Genomics Tools, and Recent Partnerships Pharmaceutical Technology Magazine
dlvr.it
March 5, 2025 at 5:31 PM
Everybody can reply
Thoughts on this? >> CytomX, Amgen pass on T cell engager; Molecular Partners
ends work with Novartis: Plus, news about Atea Pharmaceuticals: CytomX, Amgen stop work on T… >> Comment below! #strategy #competitiveintelligence #marketing #productmarketing #pharma #pharmaceutical #healthcare #biotech
ends work with Novartis: Plus, news about Atea Pharmaceuticals: CytomX, Amgen stop work on T… >> Comment below! #strategy #competitiveintelligence #marketing #productmarketing #pharma #pharmaceutical #healthcare #biotech
CytomX, Amgen pass on T cell engager; Molecular Partners
ends work with Novartis
Plus, news about Atea Pharmaceuticals: CytomX, Amgen stop work on T cell engager: The partners decided to end development of an EGFR-targeting T cell engager based on “clinical observations to date ...
dlvr.it
March 7, 2025 at 3:57 PM
Everybody can reply
1 likes
Thoughts on this? >> Uniphar Secures 10th Cell and Gene Therapy Project -
Business Wire >> Comment below! #strategy #competitiveintelligence #marketing #competitivemarketing #pharmaceutical #biotech #healthcare #pharma
Business Wire >> Comment below! #strategy #competitiveintelligence #marketing #competitivemarketing #pharmaceutical #biotech #healthcare #pharma
Uniphar Secures 10th Cell and Gene Therapy Project -
Business Wire
Uniphar Secures 10th Cell and Gene Therapy Project Business Wire
dlvr.it
April 23, 2025 at 12:00 AM
Everybody can reply
Thoughts on this? >> Is Ionis Pharmaceuticals, Inc. (IONS) a Promising Biotech
Stock According to Wall Street Analysts - Yahoo Finance >> Comment below! #strategy #competitiveintelligence #marketing #competitivemarketing #pharma #biotech #pharmaceutical #healthcare
Stock According to Wall Street Analysts - Yahoo Finance >> Comment below! #strategy #competitiveintelligence #marketing #competitivemarketing #pharma #biotech #pharmaceutical #healthcare
Is Ionis Pharmaceuticals, Inc. (IONS) a Promising Biotech
Stock According to Wall Street Analysts - Yahoo Finance
Is Ionis Pharmaceuticals, Inc. (IONS) a Promising Biotech Stock According to Wall Street Analysts Yahoo Finance
dlvr.it
April 15, 2025 at 1:30 PM
Everybody can reply
Thoughts on this? >> 'One of the lucky few': Bicara's CEO on operating in today's
market, while hoping for a different one >> Comment below! #strategy #competitiveintelligence #marketing #pharmaceutical #biotech #healthcare #pharma #competitivemarketing
market, while hoping for a different one >> Comment below! #strategy #competitiveintelligence #marketing #pharmaceutical #biotech #healthcare #pharma #competitivemarketing
'One of the lucky few': Bicara's CEO on operating in today's
market, while hoping for a different one
Amid an FDA overhaul and market volatility, one biotech executive says her public company still operates with the mentality of a private company, while urging the industry to work together with federal health agencies so drug developers can continue to transform cancer care.
dlvr.it
April 15, 2025 at 1:30 PM
Everybody can reply
Thoughts on this? >> Making cell therapy accessible: challenges and opportunities
- Nature >> Comment below! #strategy #competitiveintelligence #marketing #pharma #pharmaceutical #competitivemarketing #biotech #healthcare
- Nature >> Comment below! #strategy #competitiveintelligence #marketing #pharma #pharmaceutical #competitivemarketing #biotech #healthcare
Making cell therapy accessible: challenges and opportunities
- Nature
Making cell therapy accessible: challenges and opportunities Nature
dlvr.it
April 15, 2025 at 12:30 PM
Everybody can reply